TGW211 is a next-generation, first-in-class HER2-directed radioimmunoconjugate developed based on Tagworks’ proprietary Click-to-Release – bioorthogonal, in vivo click chemistry – linker platform TGW211 is designed to achieve strong tumor uptake...
Investment philosophy
Venture&Growth
Private Equity
Team
Our transatlantic team, comprising sector specialists with operating and financial backgrounds leverages its deep industry knowledge to achieve outsized returns on impactful companies active in healthcare or climate solutions.
Portfolio
Our portfolio consists of impactful companies providing solutions for healthcare and climate related challenges. The Healthcare Private Equity fund invests in profitable firms that support the healthcare sector such as healthcare providers, medical product suppliers, and service providers. The Healthcare Venture&Growth fund invests in disruptive companies active in medtech, digital health, medical instruments, and therapeutics. The Climate Solutions fund invests in profitable companies active in energy transition, biodiversity and waste & pollution.

Performation
Performation is a provider of healthcare-specific business intelligence solutions. Headquartered in Zeist, the Netherlands, its software products enable clie...

Withings
Withings is a leading French healthtech company focused on commercializing personal health devices and services for the accurate collection of patient-genera...

Symeres
Symeres, previously known as Mercachem and Syncom, is a leading mid-sized European contract research organization (CRO) for integrated outsourced drug discov...

Responsible Investment at Gilde Healthcare:
We focus on both ESG and Impact: ESG sets the foundation with responsible practices, while Impact drives measurable change in healthcare. Check out our impact cases to see how we’re making a difference.
Read more about ESG/impactNieuws
Keep up to date with Gilde Healthcare announcements and portfolio company news.